Skip to main content
Premium Trial:

Request an Annual Quote

Tm Bioscience to be Listed on Toronto Stock Exchange; Plans Share Consolidation

NEW YORK, Feb. 27 (GenomeWeb News) - Tm Bioscience has received conditional approval to list its common shares on the Toronto Stock Exchange, the company said yesterday.


The Toronto-based company expects full approval by May 26. CEO and president Greg Hines said he hopes the listing will "greatly enhance our profile among a broader group of investors."


Tm Bioscience also plans to consolidate its shares by converting each five common shares into one. It intends to obtain shareholder approval for this share consolidation at its annual meeting, scheduled for June 2.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.